Ronald Hunt, Director, 10% Owner at Harpoon Therapeutics, Inc. (HARP), bought 235,294 shares at $17.00 ($4.0M) on 2021-01-11, disclosed to the SEC on 2021-08-12.
Open-market purchase of $4.0M HARP by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| ITRM | BUY | 2018-05-31 | $8.6M | — | Filing → |
| MEIP | SELL | 2014-12-10 | $476K | — | Filing → |
| RLYP | BUY | 2013-11-20 | $2.0M | — | Filing → |